SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon to tap atorvastatin market in US

12 Mar 2012 Evaluate

Biocon is planning to sell anti-cholesterol drug, atorvastatin, in the USfrom FY2013. The US market for atorvastatin opened up recently for genericcompanies. Biocon plans to follow Watson and Ranbaxy, which have alreadyreleased their products and are currently under six months' exclusivity phase.

The companyhas partnerships for atorvastatin active ingredient and we expect thesepartners to commercialise the products in the US from FY13 onwards.  The company is one of the largest producersof statins. The company has seen a significant growth in branded atorvastatin(Statix) as well as sales of active pharmaceutical ingredients (API). Biocon isplanning to tap the European market, where it is currently selling atorvastatinwith its partners. In Europe, a few countries are still open, but the patentsare expiring. Biocon has major presence in emerging and unregulated marketswith its branded atorvastatin (Statix). On the company's biopharmaceuticalsbusiness, the existing products continue to grow and new launches will happen.Emerging markets will be growing with the new product launches happening there.

Biocon Share Price

358.20 7.65 (2.18%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×